Dr Jason Scott Taub, MD | |
6101 W Plano Pkwy Ste 100, Plano, TX 75093-8201 | |
(214) 750-3646 | |
Not Available |
Full Name | Dr Jason Scott Taub |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 17 Years |
Location | 6101 W Plano Pkwy Ste 100, Plano, Texas |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932383205 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 002279 (Georgia) | Secondary |
207T00000X | Neurological Surgery | P6733 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White Medical Center Plano | Plano, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dallas Neurosurgical Associates Pa | 1254386907 | 15 |
News Archive
Today's headlines focus on state decisions regarding new health insurance pools; insurers' plans regarding the early adoption of some reform law provisions; and, of course, the politics that continue to surround health reform.
Biomoda, Inc., a development stage medical diagnostics company, announced it has been granted a notice of allowance from the U.S. Patent and Trademark Office for its invention directed to the "Method for Prognosing Response to Cancer Therapy with 5,10,15,20-Tetrakis (Carboxyphenyl) Porphine."
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.
Wellness Formulations, LLC, a leader in anti-glycation research and product development, has launched Dermal Renu® Sunshield daily wear SPF 15 sunscreen. This mineral based sunscreen provides broad-spectrum protection from sun damage caused by UVA/UVB rays, while fighting the signs of aging through a unique combination of anti-glycation agents, antioxidants, moisturizing elements, peptides, and botanical extracts.
Lumenis Ltd., the world's largest medical laser company, announced today that it supplied an UltraPulse SurgiTouch CO2 laser with Digital AcuBlade microsurgery system to the Landspitalinn University Hospital in Reykjavik, Iceland. Lumenis' state of the art laser system, was used by Dr. Paul Castellanos to perform Trans-oral Laser Microsurgery (TLM) for the treatment of airway stenosis with obstructing neurofibromatosis of the laryngopharynx on a 9-year-old girl and four other patients.
› Verified 4 days ago
Entity Name | Dallas Neurosurgical Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083600951 PECOS PAC ID: 1254386907 Enrollment ID: O20050316000277 |
News Archive
Today's headlines focus on state decisions regarding new health insurance pools; insurers' plans regarding the early adoption of some reform law provisions; and, of course, the politics that continue to surround health reform.
Biomoda, Inc., a development stage medical diagnostics company, announced it has been granted a notice of allowance from the U.S. Patent and Trademark Office for its invention directed to the "Method for Prognosing Response to Cancer Therapy with 5,10,15,20-Tetrakis (Carboxyphenyl) Porphine."
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.
Wellness Formulations, LLC, a leader in anti-glycation research and product development, has launched Dermal Renu® Sunshield daily wear SPF 15 sunscreen. This mineral based sunscreen provides broad-spectrum protection from sun damage caused by UVA/UVB rays, while fighting the signs of aging through a unique combination of anti-glycation agents, antioxidants, moisturizing elements, peptides, and botanical extracts.
Lumenis Ltd., the world's largest medical laser company, announced today that it supplied an UltraPulse SurgiTouch CO2 laser with Digital AcuBlade microsurgery system to the Landspitalinn University Hospital in Reykjavik, Iceland. Lumenis' state of the art laser system, was used by Dr. Paul Castellanos to perform Trans-oral Laser Microsurgery (TLM) for the treatment of airway stenosis with obstructing neurofibromatosis of the laryngopharynx on a 9-year-old girl and four other patients.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jason Scott Taub, MD 6101 W Plano Pkwy Ste 100, Plano, TX 75093-8201 Ph: (214) 750-3646 | Dr Jason Scott Taub, MD 6101 W Plano Pkwy Ste 100, Plano, TX 75093-8201 Ph: (214) 750-3646 |
News Archive
Today's headlines focus on state decisions regarding new health insurance pools; insurers' plans regarding the early adoption of some reform law provisions; and, of course, the politics that continue to surround health reform.
Biomoda, Inc., a development stage medical diagnostics company, announced it has been granted a notice of allowance from the U.S. Patent and Trademark Office for its invention directed to the "Method for Prognosing Response to Cancer Therapy with 5,10,15,20-Tetrakis (Carboxyphenyl) Porphine."
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.
Wellness Formulations, LLC, a leader in anti-glycation research and product development, has launched Dermal Renu® Sunshield daily wear SPF 15 sunscreen. This mineral based sunscreen provides broad-spectrum protection from sun damage caused by UVA/UVB rays, while fighting the signs of aging through a unique combination of anti-glycation agents, antioxidants, moisturizing elements, peptides, and botanical extracts.
Lumenis Ltd., the world's largest medical laser company, announced today that it supplied an UltraPulse SurgiTouch CO2 laser with Digital AcuBlade microsurgery system to the Landspitalinn University Hospital in Reykjavik, Iceland. Lumenis' state of the art laser system, was used by Dr. Paul Castellanos to perform Trans-oral Laser Microsurgery (TLM) for the treatment of airway stenosis with obstructing neurofibromatosis of the laryngopharynx on a 9-year-old girl and four other patients.
› Verified 4 days ago
Dr. Thomas Adam Kosztowski, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 W 15th St Ste 455, Plano, TX 75093 Phone: 469-782-0660 | |
Dr. Scott Kutz, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 133, Plano, TX 75024 Phone: 972-244-3491 Fax: 972-535-2181 | |
Richard L Weiner, M.D. Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 6101 W Plano Pkwy Ste 100, Plano, TX 75093 Phone: 214-750-3646 | |
Gary C Dennis, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 7150 Preston Rd, Bldg 3, Suite 300, Plano, TX 75024 Phone: 214-705-9599 Fax: 214-705-9590 | |
Todd Stiles Shanks, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5425 W Spring Creek Pkwy Ste 133, Plano, TX 75024 Phone: 972-535-2170 Fax: 972-535-2181 | |
Luis A Mignucci, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 6160 Windhaven Pkwy, 200, Plano, TX 75093 Phone: 972-378-6908 Fax: 972-378-6749 | |
David L Masel, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7150 Preston Rd, Bldg 3, Suite 300, Plano, TX 75024 Phone: 214-705-9599 Fax: 214-705-9590 |